Greg Downey

Greg Downey has over 25 years of helping promising start-up, growth, and public companies increase sales and market leadership in the United States, and abroad. His operational experience covers areas such as business development, product commercialization, branding, marketing, sales, distribution, turnarounds, M&A, and building strategic industry and investor relationships that create great companies. His personal efforts have generated hundreds of millions in revenue, contributed to multiple licensing transactions, mergers, and acquisitions. Greg has led over $550M in private financings for early-stage and growth companies and actively collaborates with leaders in healthcare and technology.

Greg began his career by helping launch a minimally invasive surgical division of Johnson & Johnson that became the global leader in women’s health and urology. He then went on to serve in executive sales, marketing, and business development roles for Medibuy, a venture backed by Kleiner Perkins, Sequoia Capital, and Goldman Sachs.  After the sale of Medibuy, Greg joined NoInk Communications, a mobile software company spun out of Rose-Hulman Institute of Technology. At NoInk, Greg created and implemented sales and marketing strategies that resulted in the company becoming the leader in the medical device industry. The company was eventually acquired by the Global Healthcare Exchange (GHX), the leading global healthcare cloud-based supply chain network. Greg then went on to assist an EU-based venture capital firm with launching Swedish AI middleware software company, Appear Networks, into US security markets and eventually into healthcare through partnerships with Cisco, Intel, and Siemens. 

Greg then invested and joined the founding team of OrthoPediatrics, a company focused on providing innovative orthopedic and biologic solutions for children with musculoskeletal conditions. As a board member and vice president over marketing and business development, he created the company’s branding strategy, recruited top surgeons, formed strategic partnerships, led three capital raises, as well as technology transfer initiatives with notable institutions like the Cleveland Clinic, Case Western Reserve University, and the University of California San Francisco. OrthoPediatrics became a publicly traded company in October 2017 (NASDAQ: KIDS) and is regarded as one of the top 10 performing IPOs of 2017.

In 2010, Greg co-founded Purim Ventures, a global venture studio and investment firm focused on providing strategic advisory and business development services to start-ups and growth companies, as well as to institutional and private investors. Purim also works with family offices and private equity funds in the areas of due diligence, subject matter expertise, and deal sourcing. 

In 2023, Greg launched the Capital Mastermind where he and his team work with driven founders looking to scale their businesses and master the art of raising capital from private investors and family offices. Through his unique hands-on approach and proprietary system and methods, Mastermind clients have received over $1B in term sheets. 

Greg is a sought after speaker at family office and private investor events and serves as an advisor or on the board of several non-profit organizations and privately held companies, including PolyXLabs, Exodus New Ventures, TrueRelief, CareNET, Brontide, Beyond Wellness, and the University of South Florida’s CONNECT Research & Innovation Center. He also serves as a senior advisor to one of the most successful Service-Disabled Veteran Owned Small Business (SDVOSB) healthcare distribution companies in the U.S. serving the Veterans Health Administration, a network of over 170 medical centers with over 9 million enrolled military family lives.